MSG
Biological Impact & Mechanism
Neurotransmitter Stimulation: MSG provides a surge of free glutamate, which binds to NMDA and AMPA receptors in the brain. In sensitive individuals, this can cause "over-firing" of neurons.
Insulin Response: Emerging studies suggest that MSG may stimulate the pancreas to release insulin, even in the absence of carbohydrates, potentially contributing to metabolic syndrome or leptin resistance over time.
Leptin Interference: Some animal models show that MSG consumption can disrupt the arcuate nucleus in the brain, which regulates the hormone leptin, potentially leading to a lack of "fullness" signaling and subsequent overeating.
Historical & Common Use
MSG was discovered in 1908 by Japanese chemist Kikunae Ikeda, who isolated the substance from kelp (Kombu). He identified the taste as "Umami." By 1909, the Ajinomoto corporation began mass-producing MSG. It became a staple in military rations during WWII to make bland food palatable and was subsequently adopted by the burgeoning American fast-food and canned-soup industries in the 1950s.
Consumer Sentiments
Consumer Reports of Health Effects and Symptoms
The "MSG Symptom Complex" includes frequent reports of:
Neurological: Throbbing headaches (migraines), dizziness, and "brain fog."
Dermatological: Flushing of the face, neck, and arms; excessive sweating.
Cardiovascular: Palpitations or a rapid, fluttering heartbeat.
Sensory: Numbness or tingling in the extremities and a feeling of pressure in the facial muscles.
FDA & Other Regulatory Authorities
FDA (USA): Classified as GRAS (Generally Recognized As Safe). As of 2026, the FDA maintains that most people can consume MSG without issue, though it mandates that MSG must be listed by its common name on labels. It cannot be hidden under "Spices" but can sometimes be part of "Natural Flavors" if the glutamate is naturally occurring in an extract.
EFSA (EU): In July 2017, EFSA established a "Group Acceptable Daily Intake" (ADI) for glutamates at 30 mg/kg of body weight per day. This was a significant shift, as previously there was no numerical limit.
WHO Western Pacific / JECFA: Consistently rates MSG as having a "not specified" ADI, meaning it is considered very low toxicity. However, WHO guidelines for the region emphasize reducing sodium intake, noting that MSG contributes to total sodium consumption (though it contains about 1/3 the sodium of table salt).
USDA: Permits the use of MSG in meat and poultry products but requires clear labeling on the package to ensure consumers are aware of its presence for sensitivity reasons.